<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>StemCells Therapy</title>
	<link>http://www.stemcellstherapy.tv</link>
	<description>Stem Cells Therapy and Stem Cell Research</description>
	<lastBuildDate>Wed, 16 May 2012 09:11:59 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.2.1" -->

	<item>
		<title>Stem Cells May Help Heart Patients</title>
		<description><![CDATA[ What if your very own bone marrow stem cells, upgraded with more immune cells, could be used to increase your chances of survival after a heart attack? Sounds like the stuff of science fiction, but according to a study done by Timothy Henry, MD of the Minneapolis Heart Institute and colleagues, it may in fact be possible. ]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cells/stem-cells-may-help-heart-patients.php</link>
			</item>
	<item>
		<title>Bacterial magnets and the bio-computer era</title>
		<description><![CDATA[ Bacterial magnets and the bio-computer era By Raja Murthy MUMBAI - Scientists are working to have some of the world's smallest creatures carry the growing mountain-loads of information worldwide - the next generation of information technology and medical devices based on bacteria, biology and billions of years of evolution. Researchers from Tokyo University of Agriculture and Technology and University of Leeds are studying bacteria that produce magnets, and how these can be used to produce faster, cheaper, environmentally friendly electronics and computers. Magnetospirilllum magneticum are the microbial heroes in this story. ]]></description>
		<link>http://www.stemcellstherapy.tv/nano-medicine/bacterial-magnets-and-the-bio-computer-era.php</link>
			</item>
	<item>
		<title>Top Sierra Tucson Docs to Present at Mindfulness Conference This Week</title>
		<description><![CDATA[ PHOENIX, AZ (PRWEB) May 16, 2012 This week, experts, thought leaders and health professionals will gather in the Phoenix area (Goodyear) for a national conference on mindfulness, one of the most popular new treatment approaches in the field of psychotherapy. The Art &#038; Science of Mindfulness &#038; Counseling: A Revolution of the Heart conference will be held May 16-19, 2012 at the Wigwam Golf Resort &#038; Spa, and will feature two Sierra Tucson physicians, Robert Johnson, D.O., Medical Director, and James Duffy, M.D., Psychiatrist and Chief of Integrative Medicine, along with Jack Kornfield, Ph.D., a renowned expert in the mindfulness field. The conference is hosted by FACES Conferences, a leading provider of education and conferences dedicated to mindfulness]]></description>
		<link>http://www.stemcellstherapy.tv/integrative-medicine/top-sierra-tucson-docs-to-present-at-mindfulness-conference-this-week.php</link>
			</item>
	<item>
		<title>Abraham’s genetic threads &#124; Gene Expression</title>
		<description><![CDATA[ Every few days my Google Alerts have been dropping in my inbox reviews of Harry Osters Legacy: A Genetic History of the Jewish People. The latest, is in the The Tablet, A Case for Genetic Jewishness: For a Jewish genetics researcher, being told inprintthat Hitler would certainly have been very pleased by your work cant be pleasant. ]]></description>
		<link>http://www.stemcellstherapy.tv/genetic-medicine/abraham%e2%80%99s-genetic-threads-gene-expression.php</link>
			</item>
	<item>
		<title>Gene Therapy Extends Mouse Lifespan</title>
		<description><![CDATA[ 33054641 story Posted by Soulskill on Tuesday May 15, @08:17PM from the boosterspice-before-i-get-old-please dept. Grond writes "ScienceDaily reports, 'Researchers at the Spanish National Cancer Research Centre have demonstrated that the mouse lifespan can be extended by the application in adult life of a single treatment acting directly on the animal's genes. ]]></description>
		<link>http://www.stemcellstherapy.tv/gene-therapy/gene-therapy-extends-mouse-lifespan.php</link>
			</item>
	<item>
		<title>Angel Biotechnology &#8211; Angel signs new contract with ReNeuron</title>
		<description><![CDATA[ 16 May 2012 Angel Biotechnology Holdings plc ("Angel" or "the Company") Angel signs new contract with ReNeuron to provide GMP (KOSDAQ: 018290.KQ - news) cell manufacturing services for completion of stroke clinical trial Angel Biotechnology Holdings plc, (AIM:ABH), the biopharmaceutical contract manufacturer, has signed a new contract with ReNeuron Group (Berlin: RQE.BE - news) plc (AIM:RENE) to perform GMP manufacturing services in support of the final part of the PISCES Phase 1 clinical trial of its ReN001 stem cell therapy for stroke; the value of the contract was not disclosed. ]]></description>
		<link>http://www.stemcellstherapy.tv/biotechnology/angel-biotechnology-angel-signs-new-contract-with-reneuron.php</link>
			</item>
	<item>
		<title>Study identifies how skeletal muscle stem cells respond to muscle injury</title>
		<description><![CDATA[ A study conducted by Children's Hospital &#038; Research Center Oakland scientists identifies how skeletal muscle stem cells respond to muscle injury and may be stimulated to improve muscle repair in Duchenne Muscular Dystrophy, a severe inherited disease of muscle that causes weakness, disability and, ultimately, heart and respiratory failure. The study, led by Julie D. ]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cells/study-identifies-how-skeletal-muscle-stem-cells-respond-to-muscle-injury.php</link>
			</item>
	<item>
		<title>New York Stem Cell Foundation scientist grows bone from human embryonic stem cells</title>
		<description><![CDATA[ Public release date: 14-May-2012 [ &#124; E-mail &#124; Share ] Contact: David McKeon dmckeon@nyscf.org 212-365-7440 New York Stem Cell Foundation NEW YORK, NY (May 14, 2012) -- Dr. Darja Marolt, an Investigator at The New York Stem Cell Foundation (NYSCF) Laboratory, is lead author on a study showing that human embryonic stem cells can be used to grow bone tissue grafts for use in research and potential therapeutic application. Dr]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cells/new-york-stem-cell-foundation-scientist-grows-bone-from-human-embryonic-stem-cells.php</link>
			</item>
	<item>
		<title>Human embryonic stem cells can be used to grow bone tissue grafts</title>
		<description><![CDATA[ Published on May 15, 2012 at 5:02 AM Dr. Darja Marolt, an Investigator at The New York Stem Cell Foundation (NYSCF) Laboratory, is lead author on a study showing that human embryonic stem cells can be used to grow bone tissue grafts for use in research and potential therapeutic application]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cells/human-embryonic-stem-cells-can-be-used-to-grow-bone-tissue-grafts.php</link>
			</item>
	<item>
		<title>Bone grown from human embryonic stem cells</title>
		<description><![CDATA[ Washington, May 15 : In a new study, researchers have shown that human embryonic stem cells can be used to grow bone tissue grafts for use in research and potential therapeutic application. The study is the first example of using bone cell progenitors derived from human embryonic stem cells to grow compact bone tissue in quantities large enough to repair centimeter-sized defects. When implanted in mice and studied over time, the implanted bone tissue supported blood vessel ingrowth, and continued development of normal bone structure, without demonstrating any incidence of tumor growth. ]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cells/bone-grown-from-human-embryonic-stem-cells.php</link>
			</item>
	<item>
		<title>Pluristem trial finds stem cells improve cardiac dysfunction</title>
		<description><![CDATA[ Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) today reported that the cardiac function in a diabetic-induced diastolic dysfunction in animals improved following PLacental eXpanded (PLX cells) administration]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cells/pluristem-trial-finds-stem-cells-improve-cardiac-dysfunction.php</link>
			</item>
	<item>
		<title>Stem Cell Market &amp; Cord Blood Banking Industry Research Reports at 10% Discount &#8211; Limited Period Offer</title>
		<description><![CDATA[ DALLAS, May 15, 2012 /PRNewswire/ -- ReportsnReports.com announces a Flat 10% Discount on ALL market research reports by BioInformant WorldWide, LLC through June 20, 2012. ]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cells/stem-cell-market-cord-blood-banking-industry-research-reports-at-10-discount-limited-period-offer.php</link>
			</item>
	<item>
		<title>Scientists discover clues to muscle stem cell functions</title>
		<description><![CDATA[ ScienceDaily (May 15, 2012) A study conducted by Children's Hospital &#038; Research Center Oakland scientists identifies how skeletal muscle stem cells respond to muscle injury and may be stimulated to improve muscle repair in Duchenne Muscular Dystrophy, a severe inherited disease of muscle that causes weakness, disability and, ultimately, heart and respiratory failure. The study, led by Julie D. Saba, MD, PhD, senior scientist at Children's Hospital Oakland Research Institute (CHORI), shows that a lipid signaling molecule called sphingosine-1-phosphate or "S1P" can trigger an inflammatory response that stimulates the muscle stem cells to proliferate and assist in muscle repair]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cells/scientists-discover-clues-to-muscle-stem-cell-functions.php</link>
			</item>
	<item>
		<title>Human Embryonic Stem Cells Used To Grow Bone Tissue</title>
		<description><![CDATA[ May 15, 2012 A New York Stem Cell Foundation (NYSCF) scientist has shown in new research that human embryonic stem cells can be used to grow bone tissue grafts for use in research and potential medical applications. Dr. Darja Marolt, an investigator at the NYSCF, is the lead author of the study, which was published this week in the online edition of the Proceedings of the National Academy of Sciences (PNAS). ]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cells/human-embryonic-stem-cells-used-to-grow-bone-tissue.php</link>
			</item>
	<item>
		<title>Stem cell co Gamida Cell raises $10m</title>
		<description><![CDATA[ Stem cell therapies developer Gamida Cell Ltd. ]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cell-therapy/stem-cell-co-gamida-cell-raises-10m.php</link>
			</item>
	<item>
		<title>Vet undertakes stem cell surgery</title>
		<description><![CDATA[ Animal stem cell regenerative therapy is the newest service at the Animal Hospital of Tiffin. "We are the official first site for the therapy in Ohio," said veterinarian Bob McClung. The technology uses an adult animal's stem cells to heal itself. ]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cell-therapy/vet-undertakes-stem-cell-surgery.php</link>
			</item>
	<item>
		<title>Stem cell banking firms to deploy marketing initiatives to boost sales</title>
		<description><![CDATA[ Kolkata, May 15: Stem cell banking companies are looking at aggressive marketing initiatives to move into the mass market segment. Direct marketing to customers and reduction in price tag for storing umbilical cord blood are on the cards]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cell-therapy/stem-cell-banking-firms-to-deploy-marketing-initiatives-to-boost-sales.php</link>
			</item>
	<item>
		<title>International Stem Cell Corporation Scientists to Present Pre-Clinical Research Results at American Society of Gene &#8230;</title>
		<description><![CDATA[ CARLSBAD, Calif.--(BUSINESS WIRE)-- International Stem Cell Corporation (OTCBB: ISCO.OB - News) (www.internationalstemcell.com) today announced that several of its leading scientists will present experimental results from three of ISCOs pre-clinical therapeutic programs. ]]></description>
		<link>http://www.stemcellstherapy.tv/stem-cell-therapy/international-stem-cell-corporation-scientists-to-present-pre-clinical-research-results-at-american-society-of-gene.php</link>
			</item>
	<item>
		<title>AxoGen, Inc. Announces Record First Quarter 2012 Revenues</title>
		<description><![CDATA[ ALACHUA, Fla.--(BUSINESS WIRE)-- AxoGen, Inc. (AXGN.OB), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced revenues for the first quarter ended March 31, 2012 of $1.65 million, a 47% increase over 2011 first quarter revenues of $1.12 million. This quarters record performance has been the direct result of our increase in sales and marketing activity, commented Karen Zaderej, Chief Executive Officer of AxoGen, Inc]]></description>
		<link>http://www.stemcellstherapy.tv/regenerative-medicine/axogen-inc-announces-record-first-quarter-2012-revenues.php</link>
			</item>
	<item>
		<title>Histogenics’ NeoCart for Patients with Knee Cartilage Damage Demonstrates Continued Efficacy for Periods of Up to Five &#8230;</title>
		<description><![CDATA[ WALTHAM, Mass.--(BUSINESS WIRE)-- Regenerative medicine company Histogenics Corporation, announced today the presentation of intermediate term data supporting the clinical efficacy of the Companys NeoCart Autologous Cartilage Tissue Implant (ACTI) for periods of up to five years with no evidence of severe treatment-related adverse events in patients with grade III chondral injury to the femur (cartilage damage in the knee). Dennis Crawford,M.D., Ph.D.,Assistant Professor and Surgical Director of Sports Medicine Programs in the Department of Orthopedics and Rehabilitation at Oregon Health Science University presented the findings An Autologous Cartilage Tissue Implant (ACTI) NeoCart for Treatment Grade III Chondral Injury to the Femur. Intermediate Term Results from Initial FDA Trials. ]]></description>
		<link>http://www.stemcellstherapy.tv/regenerative-medicine/histogenics%e2%80%99-neocart-for-patients-with-knee-cartilage-damage-demonstrates-continued-efficacy-for-periods-of-up-to-five.php</link>
			</item>
</channel>
</rss>

